Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.


Search Results to Thomas William Flaig

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Flaig, Thomas

Item TypeName
Academic Article A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer.
Academic Article Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
Academic Article Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
Academic Article Prostate cancer in a man with multiple previous cancers.
Academic Article Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial.
Academic Article Management of the side effects of androgen deprivation therapy in men with prostate cancer.
Academic Article Adjuvant medical therapy for prostate cancer.
Academic Article A renaissance in the medical treatment of advanced prostate cancer.
Academic Article Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.
Academic Article Low-dose diethylstilbestrol for the treatment of advanced prostate cancer.
Academic Article Optimizing outcomes of advanced prostate cancer: drug sequencing and novel therapeutic approaches.
Academic Article Prostate cancer: celecoxib trampled in the STAMPEDE trial.
Academic Article Increased survival with enzalutamide in prostate cancer after chemotherapy.
Academic Article Optimal management of recurrent prostate cancer in older patients.
Academic Article A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
Academic Article Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.
Academic Article A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
Academic Article High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Academic Article Bicalutamide-associated fulminant hepatotoxicity.
Academic Article Silibinin suppresses CD44 expression in prostate cancer cells.
Academic Article Abiraterone and increased survival in metastatic prostate cancer.
Academic Article Redefining hormone sensitive disease in advanced prostate cancer.
Academic Article Abiraterone in metastatic prostate cancer without previous chemotherapy.
Concept Prostatic Neoplasms
Academic Article Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer.
Academic Article Sequencing medical therapy in prostate cancer: not as easy as 1-2-3.
Academic Article The prognostic significance of Gleason scores in metastatic prostate cancer.
Academic Article Geriatric considerations in the treatment of advanced prostate cancer.
Academic Article Visceral metastases in prostate cancer: an underestimated and understudied subgroup.
Academic Article Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Academic Article Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
Academic Article Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer.
Academic Article Upfront Chemotherapy for Metastatic Prostate Cancer.
Academic Article Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.
Academic Article Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials.
Academic Article Treatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world data.
Academic Article Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
Academic Article Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database.
Academic Article Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Academic Article Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Academic Article Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.
Academic Article Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction.
Academic Article Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.
Academic Article Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
Academic Article Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.
Academic Article Initiation of ADT in a Man With Locally Advanced Prostate Cancer and Multiple Cardiovascular Risk Factors.
Academic Article Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer.
Academic Article Point-Prostate Cancer Genomic Analysis: Routine or Research Only?
Academic Article Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.
Concept Prostatic Neoplasms, Castration-Resistant
Academic Article Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.
Academic Article Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study.
Academic Article Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer.
Academic Article Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.
Academic Article TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.
Academic Article KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer.
Academic Article Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer.
Academic Article Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study.
Academic Article Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations.

Search Criteria
  • Prostatic Neoplasms

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)